Find clinical trials for Multiple Myeloma in Taipei City
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Taipei City, TWN:
This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical ben...
Phase 4
Taipei, Taiwan and 11 other locations
doses) of the study medicine (elranatamab) in participants with multiple myeloma that has come back after responding to treatment o ...
Phase 2
Taipei City, Taiwan and 38 other locations
doses of single agent belantamab in participants with refractory multiple myeloma (RRMM) who have received at least 3 prior therapi...
Phase 1
Taipei, Taiwan and 20 other locations
monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Pa...
Phase 3
Taipei, Taiwan and 220 other locations
with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple...
Phase 3
Taipei, Taiwan and 265 other locations
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spon...
Phase 3
Taipei City, Taipei, Taiwan and 154 other locations
This study aims to evaluate alternative dosing regimens of single-agent belantamab mafodotin in participants with relapsed or refractory multiple...
Phase 2
Taipei, Taiwan and 87 other locations
The purpose of this clinical trial is to (1) learn whether the BCMA-CD3 bispecific antibody elranatamab can provide more benefit to people with multiple...
Phase 3
Taipei, Taiwan and 240 other locations
Elranatamab is a bispecific antibody: binding of elranatamab to CD3-expressing T-cells and BCMA-expressing multiple myeloma cells c...
Phase 3
Taipei, Taiwan and 65 other locations
and safety of arlo-cel (BMS-986393) versus standard regimens in adult participants with Relapsed or Refractory and Lenalidomide-exposed Multiple...
Phase 3
Taipei, Taiwan and 125 other locations
Clinical trials
Research sites
Resources
Legal